Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Benzgalantamine DR by AlphaCognition for Traumatic Brain Injury: Likelihood of Approval
Benzgalantamine DR is under clinical development by AlphaCognition and currently in Phase I for Traumatic Brain Injury. According to GlobalData,...